Skip to main content

Advertisement

Log in

COMP-Ang1 promotes long-term survival of allogeneic islet grafts in a bioinert perforated chamber by inhibiting inflammation via inhibition of the TLR4 signaling pathway

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the effects of cartilage oligomeric matrix protein (COMP)- angiopoietin-1 (Ang1) on allogeneic islet graft survival in a bioinert perforated chamber.

Results

COMP-Ang1 treatment significantly decreased lipopolysaccharide-induced cell apoptosis and islet-related lymph node cell proliferation (both P < 0.01). Tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 levels in the chamber exudate were significantly lower in the COMP-Ang1 + chamber group than in the chamber group (all P < 0.05), as were the protein expression levels. COMP-Ang1 significantly inhibited the expression of Toll-like receptor 4 (TLR4) in cultured islets. Finally, full COMP-Ang1 treatment resulted in the longest survival time among the treatment groups.

Conclusion

Combined use of the bioinert perforated chamber with COMP-Ang1 is an effective strategy for improving islet allograft survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Barton FB, Rickels MR, Alejandro R, Hering BJ et al (2012) Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care 35:1436–1445

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brindle NP, Saharinen P, Alitalo K (2006) Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98:1014–1023

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cho CH, Kammerer RA, Lee HJ, Steinmetz MO, Ryu YS, Lee SH, Yasunaga K, Kim KT, Kim I, Choi HH, Kim W, Kim SH, Park SK, Lee GM, Koh GY (2004) COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci USA 101:5547–5552

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Echavarria R, Mayaki D, Neel JC, Harel S, Sanchez V, Hussain SN (2015) Angiopoietin-1 inhibits toll-like receptor 4 signalling in cultured endothelial cells: role of miR-146b-5p. Cardiovasc Res 106:465–477

    Article  PubMed  Google Scholar 

  • Fiorina P, Folli F, Bertuzzi F, Maffi P et al (2003) Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 26:1129–1136

    Article  PubMed  Google Scholar 

  • Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, Pileggi A, Poggioli R, Ichii H, Khan A, Ferreira JV, Pugliese A, Esquenazi VV, Kenyon NS, Alejandro R (2005) Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 5:2037–2046

    Article  PubMed  Google Scholar 

  • Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA (2000) Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87:603–607

    Article  CAS  PubMed  Google Scholar 

  • Jiang J, Li J, Hao X, Diao J, Liu B, Xia W, Guo S (2012) Use of autologous chondrocytes and bioinert perforated chambers to tissue engineer cartilage in vivo. J Surg Res 173:e27–e32

    Article  CAS  PubMed  Google Scholar 

  • Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN, Ahn BC, Koh GY (2000) Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 86:952–959

    Article  CAS  PubMed  Google Scholar 

  • Kim I, Moon SO, Park SK, Chae SW, Koh GY (2001) Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 89:477–479

    Article  CAS  PubMed  Google Scholar 

  • Koh GY (2013) Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol Med 19:31–39

    Article  CAS  PubMed  Google Scholar 

  • Lemieux C, Maliba R, Favier J, Theoret JF, Merhi Y, Sirois MG (2005) Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 105:1523–1530

    Article  CAS  PubMed  Google Scholar 

  • Lysy PA, Weir GC, Bonner-Weir S (2012) Concise review: pancreas regeneration: recent advances and perspectives. Stem Cells Transl Med 1:150–159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Murugan R, Venkataraman R, Wahed AS, Elder M, Hergenroeder G, Carter M, Madden NJ, Powner D, Kellum JA, Investigators HIS (2008) Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med 36:1810–1816

    Article  CAS  PubMed  Google Scholar 

  • Park KS, Shim EY, Choi BK, Moon C, Kim SH, Kim YS, Kwon CH, Joh JW, Koh GY, Kim SJ (2010) Cartilage oligomeric matrix protein-angiopoientin-1 enhances angiogenesis of isolated islet and maintains normoglycemia following transplantation. Transplant Proc 42:2653–2657

    Article  CAS  PubMed  Google Scholar 

  • Salvalaggio PR, Deng S, Ariyan CE, Millet I, Zawalich WS, Basadonna GP, Rothstein DM (2002) Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 74:877–879

    Article  CAS  PubMed  Google Scholar 

  • Syrjala SO, Nykanen AI, Tuuminen R, Raissadati A, Keranen MA, Arnaudova R, Krebs R, Koh GY, Alitalo K, Lemstrom KB (2015) Donor heart treatment with COMP-Ang1 limits ischemia-reperfusion injury and rejection of cardiac allografts. Am J Transplant 15:2075–2084

    Article  CAS  PubMed  Google Scholar 

  • Wang S, Hao X, Su Y, Yi C, Li B, Fan X, Pei J, Song Y, Xia W, Liu B, Guo S (2013) The utilization of perforated bioinert chambers to generate an in vivo isolated space for tissue engineering involving chondrocytes, mesenchymal stem cells, and fibroblasts. Tissue Eng Part C Methods 19:352–362

    Article  CAS  PubMed  Google Scholar 

  • Zhou L, Yoon SJ, Jang KY, Moon YJ, Wagle S, Lee KB, Park BH, Kim JR (2014) COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats. Plos One 9:e110593

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the Foundation of Xijing Hospital (XJZT13Z03) and the National Natural Science Foundation of China (81500450, L.N.J.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuzhong Guo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest concerning this article.

Additional information

Dalei Wang and Lina Jiang have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, D., Jiang, L., Liang, Y. et al. COMP-Ang1 promotes long-term survival of allogeneic islet grafts in a bioinert perforated chamber by inhibiting inflammation via inhibition of the TLR4 signaling pathway. Biotechnol Lett 38, 1033–1042 (2016). https://doi.org/10.1007/s10529-016-2059-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-016-2059-6

Keywords

Navigation